IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
INSILICO DRUG DESIGN AND MOLECULAR DOCKING STUDIES OF SOME NATURAL PRODUCTS AS TYROSINE KINASE INHIBITORS

Author: ASHISH SHAH, KIRTAN SANGHVI, DIPEN SUREJA, K. SETH
Abstract: Protein Tyrosine kinases regulate cell proliferation; cell differentiations and signaling processes. Tyrosine kinases involved in diverse biological processes like growth, differentiation, metabolism and apoptosis in response to external and internal stimuli, mediator of signaling cascade. Uncontrolled signaling from receptor tyrosine kinases and intracellular tyrosine kinases can lead to diseases conditions such as cancer, atherosclerosis, and psoriasis. Natural products have been the most productive sources of lead for the development of drugs particularly as anti-cancer agents and anti infectives. Therefore aim of presenting work is to study the interaction of some natural products with selected tyrosine kinase receptor by in Silico molecular docking approach. Docking studies were carried out using PyRx and Auto dock version 4.0. Validation of ligands was carried out by using Lipinski rule of five. Many of the ligands show very good binding affinity against targeted protein. Compound NP1, NP3 and NP7 have higher binding affinity comparison with standard drug Semaxinib. Higher binding affinity and drug likeliness of compound NP1, NP3 and NP7 suggest it could further explored as tyrosine kinase inhibitors.
Keyword: Natural products, tyrosine kinase, docking, ADMET study
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus